Shaq Reveals He's on a GLP-1, but Not for the Reason You Might Think

Shaq reveals he's on a GLP-1, but not for the reason you might think

Shaquille O'Neal reveals he takes Zepbound for obstructive sleep apnea, partnering with Eli Lilly to warn adults about the overlooked sleep disorder.

Basketball great Shaq fronts Lilly sleep apnoea campaign

Eli Lilly has recruited basketball legend Shaquille O'Neal to promote a sleep apnoea awareness campaign and make the case for drug treatment

Shaquille O’Neal reveals why he uses weight-loss injections

Shaquille O’Neal has spoken about his experience with GLP-1 medications, which have become globally popular for weight loss. However, unlike many others, the basketball legend did not start using them primarily for losing weight, but due to an unexpected medical condition. O’Neal revealed in an interview that his doctor recommended GLP-1 agonist therapy because of sleep apnea. GLP-1 drugs, originally developed for diabetes treatment, work by reg…

Eli Lilly Shifts GLP-1 Platform Beyond Weight Loss, Targeting Sleep Apnea and Depression in Parallel

Eli Lilly is widening the aperture on its blockbuster drug class. The Indianapolis drugmaker is simultaneously pushing Zepbound into sleep apnea via a celebrity-led consumer campaign and testing the same molecular mechanism against major depression in a late-stage trial. The two moves underscore a deliberate strategy to reposition GLP-1 therapies as multi-indication treatments far removed […] The post Eli Lilly Shifts GLP-1 Platform Beyond Weigh…